Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN (=<  x ULN for patients with documented liver metastases)
Aspartate aminotransferase (AST) ? .  ULN without liver metastases; must be ?   ULN with liver metastases
Alanine aminotransferase (ALT) ? .  ULN without liver metastases; must be ?   ULN with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ? .  ULN or ?   ULN for patients with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN (or =< . x ULN if liver metastases are present)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ?  x ULN; if liver metastases are present, then ?  x ULN is allowed.
Serum transaminases (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) =< . x ULN in the absence of liver metastases and =<  x ULN in case of liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (=<  x ULN in patients with liver metastases)
Alanine aminotransferase or aspartate aminotransferase < . x the ULN or <  x the ULN if secondary to liver metastasis
Within  (except as noted) days of planned treatment initiation: Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x institutional ULN OR =<  x ULN for patients with known liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) < . x ULN or <  x ULN if liver metastases
PHASE II INCLUSION CRITERIA: Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) < . x ULN or <  x ULN if liver metastases
Aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase =< . x ULN, or =<  x ULN in subjects with liver metastases within  days of treatment initiation and must be independent of hematopoietic growth factor support
In the absence of liver metastases, alanine aminotransferase (AST) and aspartate aminotransferase (ALT) should be below .  ULN. If the participant has liver metastases, ALT and AST should be below .  ULN.
alanine aminotransferase /aspartate aminotransferase (ALT/AST) ?. x ULN without, and ?  x ULN with hepatic metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN or =<  x ULN for patients with liver metastases within  weeks of pre-registration
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN or =<  x ULN if liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . ULN or =<  x ULN if liver mets are present
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ?.  institutional ULN OR ?  institutional ULN for participants with liver metastases
Alanine aminotransferase (AST) and aspartate aminotransferase (ALT) =< . x ULN (or =<  x ULN if liver metastases are present)
Patients are eligible with alanine aminotransferase (ALT) or aspartate aminotransferase (AST) up to  x ULN; (up to  x ULN if liver metastases present)
Alanine aminotransferase ?  x ULN or ?  x ULN if liver metastasis is present.
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x ULN for patients without liver metastasis, =<  times for patients with liver metastases
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =<  X ULN (or <  x ULN with liver metastases)
Aspartate aminotransferase (AST) =< . x ULN or =<  x ULN if judged by the investigator to be related to liver metastases
Alanine aminotransferase and aspartate aminotransferase =< . x ULN, (=< . x ULN with documented liver metastases) within  days prior to first dose of protocol-indicated treatment.
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ?x the ULN (?x the ULN for subjects with liver metastases)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ? . x ULN, unless liver metastases are present, then values must be ?  x ULN)
Within  days prior to registration: Aspartate aminotransferase (AST) =< . x ULN (or =<  x ULN if liver metastases)
Within  days prior to registration: Alanine aminotransferase (ALT) =< . x ULN (or =<  x ULN if liver metastases)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x institutional ULN OR =<  x ULN for subjects with liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN, unless liver metastases are present, then values must be =<  x ULN
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ?  x institutional ULN (?  x ULN in the presence of liver metastases)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ?  x ULN (or ? . x ULN if hepatic metastases are present)
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< . x ULN OR =<  x ULN for subjects with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN, unless associated with hepatobiliary metastases, in that case =<  x ULN
Within  days prior to enrollment: Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< . X ULN OR =<  X ULN for subjects with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN (results within  days before study drug administration), =<  x ULN for patients with liver metastases
Performed within  days of treatment initiation: Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< . X ULN OR =<  X ULN for subjects with liver metastases
alanine aminotransferase (ALT, SGPT) and aspartate aminotransferase (AST, SGOT) ? . x ULN (?  x ULN if liver metastases are present);
Determined within  weeks of treatment initiation: Aspartate aminotransferase (AST) =< . x ULN OR =<  x ULN for subjects with liver metastases
Determined within  weeks of treatment initiation: Alanine aminotransferase (ALT) =< . x ULN OR =<  x ULN for subjects with liver metastases
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >  x ULN (>  x ULN if liver metastases are present)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN unless liver metastases are present, in which case it must be =<  x ULN.
Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) ? . x ULN or ? x ULN if known liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN if no demonstrable liver metastases or =<  x ULN in the presence of liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =<  x ULN (ALT and AST =<  x ULN is acceptable if liver metastases are present)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =<  x ULN or =<  x ULN if liver metastases are present
In absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) should be below .  ULN. If the patient has liver metastases, ALT and AST should be <   ULN.
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT):\r\n* > . x ULN\r\n* >  x ULN, if liver metastasis present
Aspartate aminotransaminase (AST) and alanine aminotransferase (ALT) =< . x ULN OR =< . x ULN if liver metastases present
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) levels =< . x ULN; if liver metastases are present, then AST and ALT =<  x ULN
Transaminases (aspartate aminotransferase-AST and alanine aminotransferase ALT) =< . x ULN (=<  x ULN if liver metastases are present)
Aspartate aminotransferase and/or alanine aminotransferase =<  x ULN (=<  x ULN if liver metastases are present) within  days prior to CD
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN (or =< . x ULN if hepatic metastases are present)
Aspartate aminotransferase (AST) =< . x ULN; =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) =< . x ULN; =<  x ULN if liver metastases are present
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN (or =< . x ULN if hepatic metastases are present)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN or =<  x ULN for subjects with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases are present
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =<  x ULN (in the case of liver metastases, =<  x ULN)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =<  x ULN for patients without liver metastasis, =<  x ULN for liver metastases
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =<   ULN or <   ULN in the setting of liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (=<  x ULN in patients with liver metastases)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ? . x ULN without liver metastases (or ?  x ULN if liver metastases are present)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ? . x ULN (?  x ULN for subjects with liver metastases)
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) < . x institutional ULN or =<  x the institution ULN in the presence of known liver metastases
Aspartate aminotransferase (AST) =< . x ULN; note: if the patient has liver metastases present, then =<  x ULN
Alanine aminotransferase (ALT) =< . x ULN; note: if the patient has liver metastases present, then =<  x ULN
Hepatic: bilirubin <. X ULN; alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < . X ULN. Patients with known liver metastases or liver neoplasms: alanine aminotransferase (ALT) or aspartate aminotransferase (AST) < . X ULN
Within  days prior to randomization: Aspartate aminotransferase (AST) and alanine aminotransaminase (ALT) must be =< . x ULN for the lab or =<  x ULN for patients with liver metastases.
Within  days of first dose of study drug: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN; if liver metastases, then =<  x ULN
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN or =<  x upper limits of normal (ULN) if liver metastases are present =<  days prior to registration
Aspartate aminotransferase (AST) ?  x ULN OR ?  x ULN (if liver metastases present)
Alanine aminotransferase (ALT) ?  x ULN OR ?  x ULN (if liver metastases present)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN unless liver metastases are present, in which case it must be =< x ULN.
Liver function tests performed within  weeks prior to starting study therapy must have alanine aminotransferase and aspartate aminotransferase =< . x ULN (or =<  x ULN if liver metastases are present)
Aspartate aminotransferase (AST), alanine aminotransferase (ALT) or alkaline phosphatase < . x ULN OR =<  x ULN for subjects with liver metastases
To be performed within  days prior to day  of protocol therapy: Aspartate aminotransferase (AST) =< . x ULN if no liver metastases or =<  x ULN if liver metastases
To be performed within  days prior to day  of protocol therapy: Alanine aminotransferase (ALT) =< . x ULN if no liver metastases or =<  x ULN if liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN (=<  x ULN for patients with documented liver metastases)
Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) =< . x upper limit of normal (ULN) but =< . x ULN in case of liver metastases; in the presence of liver metastases the liver isoenzyme fraction must be measured and liver isoenzyme fraction (absolute value) must be =<  x ULN
In absence of liver metastases, alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN; if the patient has liver metastases, ALT and AST =< . x institutional ULN
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN in subjects without liver metastases or =< . times ULN in subjects with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN (=<  x ULN for patients with documented liver metastases)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (=<  x ULN in patients with liver metastases)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x upper limit of normal (ULN) for patients with liver metastases and =< . x ULN for patients without liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . times ULN (or . x ULN in the setting of liver metastases)
Aspartate aminotransferase (AST) =< . x ULN, or =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) =< . x ULN, or =<  x ULN if liver metastases are present
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . ULN if without liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< to . times the ULN if no liver metastases; for patients with known liver metastases, AST and ALT must be =< to  times the ULN
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x ULN for patients without liver metastases and =<  x ULN for patients with liver metastases
aspartate aminotransferase, alanine aminotransferase ? . X ULN, or ? . X ULN (if liver metastasis present)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x ULN (=<  x ULN in the presence of liver metastases)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN OR =< . x ULN if liver metastases present (within  days prior to day  of protocol therapy)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN, unless liver metastases are present, then values must be =<  x ULN)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . X ULN; <  X ULN if known hepatic metastases =<  days prior to randomization
Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) up to . x ULN if no liver metastases or ALT or AST up to  x ULN if liver metastases present
Within  h of initiating study treatment: Aspartate aminotransferase (AST) =< . x ULN OR <  x ULN for liver metastases (mets)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =<  x ULN, unless associated with hepatobiliary metastases, in that case =<  x ULN
Aspartate aminotransferase (AST) =< . X ULN (=< . X ULN if liver metastases are present)
Alanine aminotransferase (ALT) =< . X ULN (=< . X ULN if liver metastases are present)
Alanine aminotransferase (ALT), and aspartate aminotransferase (AST) =< . x ULN (for patients with liver metastases, =<  x ULN)
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< . X ULN OR =<  X ULN for subjects with liver metastases
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x ULN for patients without liver metastasis, =<  times for liver metastases
The aspartate aminotransferase (AST) and alanine aminotransferase (ALT) must not be more than . x ULN within  hours prior to enrollment, or greater than . X ULN if in the Investigators judgment it is related to liver metastases; AST and ALT may be up to  x ULN within  hours prior to enrollment in participants with hepatic metastases
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) >. x upper limit of normal (ULN) if no demonstrable liver metastases or > x ULN in the presence of liver metastases
Aspartate aminotransferase (AST) =< . x ULN, or =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) =< . x ULN, or =<  x ULN if liver metastases are present
No liver metastases: aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN; liver metastases: AST and ALT =<  x ULN
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (=<  x ULN in patients with liver metastases)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN (=<  x ULN if liver metastases are present)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) < . x ULN (or <  x ULN if known liver metastases)
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN in the absence of liver metastases; AST and ALT =<  x ULN in the presence of liver metastases
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (=<  x ULN in patients with liver metastases)
Alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases persist
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN for institution or =<  x ULN for institution if clearly attributable to liver metastases
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT): ~ . x ULN for subjects without liver metastasis ~  times for liver metastases
For subjects without liver metastases: alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) =< . x ULN (=<  x ULN if liver metastases are present)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST)  =< . x ULN or =< . x ULN for subjects with liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN (=< . ULN in the presence of liver metastases)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT): =< . x ULN for subjects without liver metastasis; =<  times for liver metastases
Alanine aminotransferase (AST) or aspartate aminotransferase (ALT) > . x ULN (or < . x ULN if liver metastases are present)
Aspartate aminotransferase (AST) / alanine aminotransferase (ALT) <  x ULN (<  x ULN for patients with documented liver metastases)
Serum transaminases (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) ? . x ULN in the absence of liver metastases or =<  ULN in case of liver metastases)
Aspartate aminotransferase ?  ULN for the reference lab (?  ULN for subjects with known hepatic metastases)
Alanine aminotransferase ?  ULN for the reference lab (?  ULN for subjects with known hepatic metastases)
Aspartate aminotransferase (AST) and alkaline phosphatase =< . x ULN (CTCAE v. grade ; AST and alanine aminotransferase [ALT] =<  x ULN [or =< . x ULN if hepatic metastases are present])
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) ?  x ULN (or <  x ULN in subjects with liver metastases or hepatocellular carcinoma).
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) =< . x ULN; if liver metastases are present, =<  x ULN
Hepatic: Direct bilirubin ?. X ULN; alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ? . X ULN. For patients with known liver metastases or liver neoplasms, then ALT or AST ? . X ULN is allowed
Aspartate aminotransferase (AST)/Alanine transferase (ALT) (SGOT/SGPT) < . x ULN for the reference laboratory or <  x ULN in the presence of liver metastases
Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT) ?. X ULN (? x ULN in patients with liver metastases)
Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< . x ULN (with or without liver metastases)
Aspartate aminotransferase (AST) and Alanine aminotransferase (ALT) ? . x ULN or ? x ULN if known liver metastases
Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) <  x ULN or <  x ULN if known liver metastases
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ? .  ULN unless liver metastases are present, in which case they must be ?   ULN
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ? .  ULN unless liver metastases are present, in which case they must be ?  ULN
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) less than or equal to . x ULN unless liver metastasis is present then up to  X ULN permitted
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases are present
Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) <  X ULN in case of liver metastases
Alanine aminotransferase (ALT) =< . x ULN or =<  x ULN if liver metastases persist
Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) <  x ULN (<  x ULN if liver metastases are present)
Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< . x ULN for patients without liver metastasis, =<  times for liver metastases
Aspartate aminotransferase (AST) =< . x upper limit of normal range (ULN); for subjects with known liver metastases =<  x ULN, and alanine aminotransferase (ALT) =< . x ULN; for subjects with known liver metastases =<  x ULN
Alanine aminotransferase (ALT) =< . x ULN OR <  x ULN for subjects with liver metastases, obtained within  days prior to C-AMT PET scan
